ac133 mutz 2 cells Search Results


ac133 mutz 2 cells  (DSMZ)
91
DSMZ ac133 mutz 2 cells
Effects of exposure to increasing concentration of cordycepin on MUTZ−2 and primary AML cell viability. ( A ) Cell viability was analyzed through Trypan blue cell count in MUTZ−2 cells after cordycepin treatment at increasing concentrations (50, 100, 200 µM) for 24 and 48 h. ( B ) Dose- and time-response cytotoxicity of the drug were analyzed by the methyl thiazole tetrazolium (MTT) assay in MUTZ−2 cells treated with increasing concentrations of cordycepin (20, 50, 100 and 200 μM) for 24, 48 and 72 h. Values are expressed as the percentage of viable cells for each condition relative to controls. ( C ) MTT assay on mononuclear cells (MNCs) from an AML patient (AML#526) with increasing concentrations of cordycepin (50, 100 and 200 μM) for 24 h. ( D ) MTT assay on primary selected cells <t>(AC133</t> + ) from an AML patient (AML#523) with increasing concentrations of cordycepin (25, 50 and 100 μM) for 24 h. The relative IC 50 for MUTZ−2 is shown as the mean ± SD (standard deviation) of at least three independent experiments; the p -values are indicated in the graphs: * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001; ANOVA and Tukey’s multiple comparisons test.
Ac133 Mutz 2 Cells, supplied by DSMZ, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ac133+mutz+2+cells/MUTZ-2/pmc10417454-36-0-4
Average 91 stars, based on 1 article reviews
ac133 mutz 2 cells - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier
scf (stem cell technologies)  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc scf (stem cell technologies)
Effects of exposure to increasing concentration of cordycepin on MUTZ−2 and primary AML cell viability. ( A ) Cell viability was analyzed through Trypan blue cell count in MUTZ−2 cells after cordycepin treatment at increasing concentrations (50, 100, 200 µM) for 24 and 48 h. ( B ) Dose- and time-response cytotoxicity of the drug were analyzed by the methyl thiazole tetrazolium (MTT) assay in MUTZ−2 cells treated with increasing concentrations of cordycepin (20, 50, 100 and 200 μM) for 24, 48 and 72 h. Values are expressed as the percentage of viable cells for each condition relative to controls. ( C ) MTT assay on mononuclear cells (MNCs) from an AML patient (AML#526) with increasing concentrations of cordycepin (50, 100 and 200 μM) for 24 h. ( D ) MTT assay on primary selected cells <t>(AC133</t> + ) from an AML patient (AML#523) with increasing concentrations of cordycepin (25, 50 and 100 μM) for 24 h. The relative IC 50 for MUTZ−2 is shown as the mean ± SD (standard deviation) of at least three independent experiments; the p -values are indicated in the graphs: * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001; ANOVA and Tukey’s multiple comparisons test.
Scf (Stem Cell Technologies), supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ac133+mutz+2+cells/stem+cell+factor+scf/pmc10417454-36-40-41
Average 90 stars, based on 1 article reviews
scf (stem cell technologies) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Effects of exposure to increasing concentration of cordycepin on MUTZ−2 and primary AML cell viability. ( A ) Cell viability was analyzed through Trypan blue cell count in MUTZ−2 cells after cordycepin treatment at increasing concentrations (50, 100, 200 µM) for 24 and 48 h. ( B ) Dose- and time-response cytotoxicity of the drug were analyzed by the methyl thiazole tetrazolium (MTT) assay in MUTZ−2 cells treated with increasing concentrations of cordycepin (20, 50, 100 and 200 μM) for 24, 48 and 72 h. Values are expressed as the percentage of viable cells for each condition relative to controls. ( C ) MTT assay on mononuclear cells (MNCs) from an AML patient (AML#526) with increasing concentrations of cordycepin (50, 100 and 200 μM) for 24 h. ( D ) MTT assay on primary selected cells (AC133 + ) from an AML patient (AML#523) with increasing concentrations of cordycepin (25, 50 and 100 μM) for 24 h. The relative IC 50 for MUTZ−2 is shown as the mean ± SD (standard deviation) of at least three independent experiments; the p -values are indicated in the graphs: * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001; ANOVA and Tukey’s multiple comparisons test.

Journal: Cancers

Article Title: Cordycepin (3′dA) Induces Cell Death of AC133 + Leukemia Cells via Re-Expression of WIF1 and Down-Modulation of MYC

doi: 10.3390/cancers15153931

Figure Lengend Snippet: Effects of exposure to increasing concentration of cordycepin on MUTZ−2 and primary AML cell viability. ( A ) Cell viability was analyzed through Trypan blue cell count in MUTZ−2 cells after cordycepin treatment at increasing concentrations (50, 100, 200 µM) for 24 and 48 h. ( B ) Dose- and time-response cytotoxicity of the drug were analyzed by the methyl thiazole tetrazolium (MTT) assay in MUTZ−2 cells treated with increasing concentrations of cordycepin (20, 50, 100 and 200 μM) for 24, 48 and 72 h. Values are expressed as the percentage of viable cells for each condition relative to controls. ( C ) MTT assay on mononuclear cells (MNCs) from an AML patient (AML#526) with increasing concentrations of cordycepin (50, 100 and 200 μM) for 24 h. ( D ) MTT assay on primary selected cells (AC133 + ) from an AML patient (AML#523) with increasing concentrations of cordycepin (25, 50 and 100 μM) for 24 h. The relative IC 50 for MUTZ−2 is shown as the mean ± SD (standard deviation) of at least three independent experiments; the p -values are indicated in the graphs: * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001; ANOVA and Tukey’s multiple comparisons test.

Article Snippet: AC133 + -MUTZ-2 cells (DSMZ ACC 271) were grown in 60% alpha-MEM (Gibco) medium, complemented with 20% fetal bovine serum (FBS), 20% vol conditioned medium by 5637 cell line (DSM ACC 35), 1% penicillin/streptomycin, 1% of glutamine and 50 ng/mL SCF (STEM CELL Technologies).

Techniques: Concentration Assay, Cell Counting, MTT Assay, Standard Deviation